The largest database of trusted experimental protocols

Md 2200

Manufactured by Bioanalytical Systems

The MD-2200 is a high-performance liquid chromatography (HPLC) system designed for analytical and preparative applications. It features a modular design, allowing for the integration of various components such as pumps, detectors, and autosamplers to create a customized configuration. The MD-2200 is capable of performing precise and reliable separations of a wide range of chemical compounds.

Automatically generated - may contain errors

5 protocols using md 2200

1

In Vivo Microdialysis Evaluation of LTG

Check if the same lab product or an alternative is used in the 5 most similar protocols
The microdialysis system consisted of a microdialysis syringe (1 mL, MDN-0100; BASi, Mt Vernon, IN, USA), a Bee syringe pump, and a fraction collector (CULEX fraction collector; BASi). Commercially available microdialysis probes (MD-2200; BASi) with membrane lengths of 5 and 2 mm were used for plasma and hippocampus sampling, respectively.
In vivo recovery was evaluated using a retrodialysis method, which measured the loss (extraction ratio) of LTG via the probe.23 (link) Microdialysis probes were implanted for plasma and hippocampus sampling as described in the “LTG concentration in plasma sampled by microdialysis” and “LTG concentration in the hippocampus sampled by microdialysis” sections; 1 μg/mL and 25 ng/mL of LTG were flushed via the blood probe and brain probe, respectively. The perfusate (Cperf) and dialysate (Cdial) concentrations of LTG were determined using HPLC and UPLC–mass spectrometry (MS). In vivo relative recovery (Rdial) of LTG across the microdialysis probe was calculated by the following equation: Rdial = (Cperf − Cdial)/Cperf.
+ Open protocol
+ Expand
2

Microdialysis of Dopamine in Nucleus Accumbens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microdialysis probes (MD-2200, BASI) were stereotactically inserted into the NAc and perfused with artificial cerebrospinal fluid (aCSF) composed of either 150 mM NaCl, 3 mM KCl, 1.4 mM CaCl2, and 0.8 mM MgCl2 in 10 mM phosphate buffer alone or, additionally, with either 10 nM naltrindole or a combination of 10 μM hexamethonium and 10 μM scopolamine (3.0 μl/min). Samples were collected every 20 min for 4 h with MStim occurring after the first 2 h. Samples were analyzed using a HPLC pump (Ultimate 3000, Dionex, Sunnyvale, CA, USA) and electrochemical detector (Coulochem III, ESA). The detector included a guard cell (5020, ESA) set at +270 mV, a screen electrode (5014B, ESA) set at −100 mV, and a detection electrode (5014B, ESA) set at +220 mV. Dopamine was separated using a C18 reverse phase column (HR-80, Thermo Fisher Scientific, Waltham, MA, USA). Mobile phase included 75 mM H2NaO4P, 1.7 mM sodium octane sulfonate, 25 μM EDTA, 0.714 mM triethylamine, and 10% acetonitrile at a flow rate of 0.5 ml/min.
+ Open protocol
+ Expand
3

Stereotaxic Implantation of Bilateral Insular and Basal Forebrain Cannulae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Animals were anaesthetized with intra-parenchymal (i.p.) injections of ketamine (70 mg/kg) and xylazine (6 mg/kg) and submitted to standard stereotaxic procedures. One set of rats was implanted with a single 23 gauge stainless steel cannula aimed at 2 mm above the left insular cortex (1.2 mm anterior, 5.5 mm lateral and 3 mm ventral to Bregma; injector protruded 3 mm from the cannula) and a microdialysis guide cannula with an infusion tube (BASi MD 2262) in the right IC (corresponding coordinates for opposite side, and 4.9 mm ventral to Bregma; probe protruded 2 mm from the cannula) [46] (Fig. 1A). Another set of rats was implanted with two (bilateral) stainless steel cannulae aimed at 2.5 mm above the NBM (1.5 mm posterior, 2.5 mm lateral and 4.9 mm ventral to Bregma; injectors protruded 2.5 mm from the cannulae) and one microdialysis guide cannula (BASi MD 2200) in the right IC (coordinates above) (Paxinos and Watson, 2004) (Fig. 1B). The infusion cannulae and microdialysis guide cannula were fixed to the skull with two surgical screws and dental acrylic cement. Stylets were inserted into the guide cannulae to prevent clogging.
+ Open protocol
+ Expand
4

In Vivo Dopamine Measurement via Microdialysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microdialysis probes (MD-2200, BASI) were stereotactically inserted into the NAc (+1.6 AP, +1.9 ML, −8.0 DV) of 7 rats per group. Artificial cerebrospinal fluid (aCSF; pH ~7.4 and osmolarity of 300–310 mOSm) composed of 150 mM NaCl, 3 mM KCl, 1.4 mM CaCl2, and 0.8 mM MgCl2 in 10 mM phosphate buffer was perfused through the probe at a rate of 3.0 µL/min. Samples were collected every 20 min for 4 h with reinstatement does of ethanol (2.5 mg/kg; IP) occurring after the first 2 h had elapsed. Determination of the DA concentration in microdialysis samples was performed using a HPLC pump (Ultimate 3000, Dionex, Sunnyvale, CA, USA) connected to an electrochemical detector (Coulochem III, ESA). The detector included a guard cell (5020, ESA) set at +270 mV, a screen electrode (5014B, ESA) set at −100 mV, and a detection electrode (5014B, ESA) set at +220 mV. Dopamine was separated using a C18 reverse phase column (HR-80, Thermo Fisher Scientific, Waltham, MA, USA). Mobile phase containing 75 mM H2NaO4P, 1.7 mM sodium octane sulfonate, 25 µM EDTA, 0.714 mM triethylamine, and 10% acetonitrile was pumped through the system at a flow rate of 0.5 mL/min.
+ Open protocol
+ Expand
5

Microdialysis of Dopamine in Nucleus Accumbens

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microdialysis probes (MD-2200, BASI) were stereotactically inserted into the NAc and perfused with artificial cerebrospinal fluid (aCSF) composed of either 150 mM NaCl, 3 mM KCl, 1.4 mM CaCl2, and 0.8 mM MgCl2 in 10 mM phosphate buffer alone or, additionally, with either 10 nM naltrindole or a combination of 10 μM hexamethonium and 10 μM scopolamine (3.0 μl/min). Samples were collected every 20 min for 4 h with MStim occurring after the first 2 h. Samples were analyzed using a HPLC pump (Ultimate 3000, Dionex, Sunnyvale, CA, USA) and electrochemical detector (Coulochem III, ESA). The detector included a guard cell (5020, ESA) set at +270 mV, a screen electrode (5014B, ESA) set at −100 mV, and a detection electrode (5014B, ESA) set at +220 mV. Dopamine was separated using a C18 reverse phase column (HR-80, Thermo Fisher Scientific, Waltham, MA, USA). Mobile phase included 75 mM H2NaO4P, 1.7 mM sodium octane sulfonate, 25 μM EDTA, 0.714 mM triethylamine, and 10% acetonitrile at a flow rate of 0.5 ml/min.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!